Clinical Trial To Assess The Efficacy Of Ajmodadi Churna In The Management Of Katigatavata With Special Reference To Lumbar Spondylosis

Randomized open label, placebo controlled clinical trial to assess the efficacy of ajmodadi churna in the management of Katigatavata with special reference to lumbar spondylosis. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060409

Enrollment

Registered

2023-12-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M47- Spondylosis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing for clinical study having Age group 40-70 years. 2. X ray lumbar spine (AP and lateral view) showing changes of lumbar spondylosis 3. Patients having signs and symptoms of Katigatvata mentioned in classics. 4. Irrespective of genders and caste and socioeconomic class. 5. The Roland and Morris low back pain and disability questionnaire score more than or equal to 5. 6. Low back pain more than 3 months.

Exclusion criteria

Exclusion criteria: 1. Patient not willing for study. 2. Patient having fracture of lumbar vertebra, disc herniation etc. 3. Patients suffering from Pelvic Inflammatory diseases. 4. Patients suffering from any other chronic systemic disorders. 5. Pregnant and lactating mother. 6. Diagnosed case of Rheumatoid arthritis, Gout etc.

Design outcomes

Primary

Measure	Time frame
To study the efficacy of ajmodadi churna on sign and symptoms of KatigatavataTimepoint: 28 days	—

Secondary

Measure	Time frame
To provide safe, reliable & economical medicine in KatigatavataTimepoint: 28 days	—

Countries

India

Contacts

Public ContactVd Sandeep Gorakh Mane

Siddhakala ayurved mahavidyalaya

drsgmane@gmail.com9730657903

Outcome results